Pharming Group N.V.

PHAR· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$10.55-2.13%

2026-09-18

Financials

Valuation Metrics

Pharming Group N.V.'s Market Cap is $745M. At end of 2025 it was $1.17B. Ranked #2615 of 3,121 in US market (top 84%), #1109 of 1,463 on NASDAQ (top 76%), #203 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 76%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$745M	US#2,615/3,121 Sec#203/266
Revenue	$366M	US#2,381/3,121 Sec#88/266
Net Income	$9M	US#2,170/3,121 Sec#71/266
Total Assets	$468M	US#2,800/3,121 Sec#174/266
Net Assets	$270M	US#2,573/3,121 Sec#163/266
Value
P/E	80.35x	US#2,063/3,121 Sec#61/266
P/B	2.75x	US#1,670/3,121 Sec#81/266
P/S	2.03x	US#1,330/3,121 Sec#32/266
EV/EBITDA	16.42x	US#1,704/3,121 Sec#44/266
FCF Yield	4.21%	US#1,603/3,121 Sec#49/266
Profitability
ROE	3.43%	US#1,931/3,121 Sec#60/266
ROA	1.98%	US#1,651/3,121 Sec#64/266
Op. Margin	3.37%	US#2,145/3,121 Sec#73/266
Revenue Growth	7.83%	US#1,497/3,121 Sec#108/266
Financial Health
Debt Ratio	73.01%	US#808/3,121 Sec#153/266
Total Debt	$113M	US#2,410/3,121 Sec#113/266
FCF	$31M	US#2,114/3,121 Sec#76/266
Cash	$158M	US#1,923/3,121 Sec#131/266
Current Ratio	3.01x	US#793/3,121 Sec#193/266
Net Debt/EBITDA	-1.05x	US#273/3,121 Sec#20/266
Performance
1Y Return	-23.88%	US#2,549/3,121 Sec#220/266
1M Return	-10.97%	US#2,402/3,121 Sec#182/266
From 52W High	-50.56%	US#2,714/3,121 Sec#212/266
1Y MDD	-53.64%	US#2,588/3,121 Sec#194/266
Trading
Volume	7,848 shares	US#3,118/3,121 Sec#265/266
Trading Value	$83188.00	US#3,119/3,121 Sec#265/266
Per Share
EPS	$0.13	US#2,079/3,121 Sec#68/266
BPS	$3.83	US#2,384/3,121 Sec#144/266